- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 75% insulin lispro protamine suspension and 25 % insulin lispro injection
Total 308 results
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
-
SanofiCompletedDiabetes Mellitus, Type 2United States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Brazil, Canada
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Canada, India, Puerto Rico, Australia, Spain, Netherlands, Hungary, Brazil, Greece, Romania, Argentina
-
Eli Lilly and CompanyCompletedDiabetes Mellitus Type 2Korea, Republic of, Hungary, United States, Mexico, Argentina, India, Poland, Taiwan, Spain
-
WockhardtWithdrawnBioequivalence in Healthy SubjectsUnited States
-
Eli Lilly and CompanyCompletedA Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsDiabetes Mellitus, Type 2Romania, Italy, Belgium, Poland, Greece, Germany, United Kingdom, Turkey, Czech Republic, Slovakia
-
GeropharmCompletedClamp StudyRussian Federation
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan, Korea, Republic of, China, Turkey
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Russian Federation, United States, Australia, Greece, Argentina, Hungary, Brazil, Mexico, Romania
-
WockhardtWithdrawnBioequivalence in Healthy SubjectsUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Taiwan, China, Korea, Republic of
-
Chongqing Medical UniversityCompleted
-
The First Affiliated Hospital of Xiamen UniversityCompletedDiabetes Mellitus, Type 2China
-
GeropharmCompletedDiabetes Mellitus, Type 2 | Diabetes MellitusRussian Federation
-
Tonghua Dongbao Pharmaceutical Co.,LtdRecruiting
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1United States
-
SanofiCompletedType 1 Diabetes MellitusUnited States, Austria, Brazil, Chile, Czech Republic, Germany, Hungary, India, Mexico, Peru, Poland, Romania, Russian Federation, South Africa, Spain, Turkey
-
Eli Lilly and CompanyCompleted
-
Halozyme TherapeuticsCompleted
-
Biocon LimitedTerminatedType 1 Diabetes MellitusIndia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Spain, United Kingdom
-
Eli Lilly and CompanyCompleted
-
Halozyme TherapeuticsCompletedType 1 Diabetes MellitusUnited States
-
Diasome PharmaceuticalsIntegriumCompletedType 1 Diabetes MellitusUnited States
-
Dance Biopharm Inc.Profil Institut für Stoffwechselforschung GmbHCompletedType 2 Diabetes MellitusGermany
-
AdociaEli Lilly and CompanyCompletedHealthy ParticipantsSingapore
-
BiodelSuspendedDiabetes MellitusUnited States
-
Universidad de GuanajuatoCompleted
-
Inreda Diabetic B.V.CompletedType 1 DiabetesNetherlands
-
SanofiCompleted
-
AdociaEli Lilly and CompanyCompleted
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusBrazil, Canada, Mexico, India, Australia, China, Korea, Republic of
-
Diasome PharmaceuticalsCompletedDiabetes Mellitus, Type 1United States
-
Eli Lilly and CompanyCompleted
-
Yanbing LiUnknownType 2 Diabetes Mellitus | Peritoneal DialysisChina
-
Dance Biopharm Inc.WCCT GlobalTerminatedSafety and TolerabilityUnited States
-
Diasome PharmaceuticalsIntegriumCompletedDiabetes Mellitus, Type 1United States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Croatia, Poland, Romania, South Africa, Turkey
-
BiodelCompletedDiabetes Mellitus Type 1United States
-
Eli Lilly and CompanyCompletedType 1 Diabetes MellitusSpain, United States, France, Israel, Australia, Germany, Italy, Puerto Rico, Austria, Hungary, Canada
-
Hompesch, Marcus, M.D.Profil Institute for Clinical Research, Inc.Unknown
-
Gan and Lee Pharmaceuticals, USAWithdrawnDiabetes Mellitus, Type 1United States, Spain, Hungary, Poland, Germany, Czechia
-
Medical University of GrazEuropean CommissionCompletedType 1 DiabetesAustria
-
Eli Lilly and CompanyCompleted